Christopher D. Maggiore bought $284K of Zivo Bioscience (ZIVO)

Executed Oct 8 2025, disclosed Oct 9 2025, 1 day later.

Value, as filed

$284K

23,682 sh × $12.01

Executed

Oct 8 2025

the trade date, as filed

Disclosed

Oct 9 2025

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

-17.9%

+8.9% from execution

Over the 21 trading sessions from the disclosed entry session (Oct 9 2025), the stock returned -17.9% (delay-adjusted); from the execution session (Oct 8 2025), +8.9%. Derived: entry at the session's open, exit at the close 20 sessions later.

The filer

CM Christopher D. Maggiore Director profile →

Christopher D. Maggiore (Director) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in ZIVO. Across 1 priced purchase filing, the average 21-session return was +8.9% from execution and -17.9% from disclosure (delay-adjusted; derived). The largest single filing was $284K of ZIVO (23,682 sh × $12.01, as filed), executed Oct 8 2025.

The name

ZIVO ZIVO ZIVO · 7 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→